Published on the 5/9/2020 from the BJSM : Scans and cardiological tests for return to play, in athletes who have suffered covid 19.
Wilson MG, et al. Br J Sports Med 2020;54:1157–1161. doi:10.1136/bjsports-2020-102710
1.Mathew G Wilson1,2, 2. James H Hull1,3,4, 3. John Rogers5,6,7, 4. Noel Pollock1,8, 5. Miranda Dodd2, 6. Jemma Haines5,6,9, 7. Sally Harris5,7, 8. Mike Loosemore1,4,
9. Aneil Malhotra5,6,10, 10. Guido Pieles1,11, 11. Anand Shah3,12, 12. Lesley Taylor5,7, 13. Aashish Vyas5,6,13, 14. Fares S Haddad1,2,14, 15. Sanjay Sharma15
SARS-CoV-2 is the causative virus responsible for the COVID-19 pandemic. This pandemic has necessitated that all professional and elite sport is either suspended, postponed or cancelled altogether to minimise the risk of viral spread. As infection rates drop and quarantine restrictions are lifted, the question how athletes can safely resume competitive sport is being asked. Given the rapidly evolving knowledge base about the virus and changing governmental and public health recommendations, a precise answer to this question is fraught with complexity and nuance. Without robust data to inform policy, return-to-play (RTP) decisions are especially difficult for elite athletes on the suspicion that the COVID-19 virus could result in significant cardiorespiratory compromise in a minority of afflicted athletes. There are now consistent reports of athletes reporting persistent and residual symptoms many weeks to months after initial COVID-19 infection. These symptoms include cough, tachycardia and extreme fatigue. To support safe RTP, we provide sport and exercise medicine physicians with practical recommendations on how to exclude cardiorespiratory complications of COVID-19 in elite athletes who place high demand on their cardiorespiratory system. As new evidence emerges, guidance for a safe RTP should be updated.
Read the full article here: RTP Covid
Fig 1 RTP pathway in those elite athletes confirmed (or suspected) COVID-19 positive. *History and physical examination should also consider other organ systems where COVID-19 can have pathological consequences such as neurological, gastrointestinal and dermatological. CPET,
cardiopulmonary exercise test; CRP, C reactive protein; CXR, chest X-ray; ECG, electrocardiogram; ECHO, echocardiography; hs-cTnT; high-sensitivity cardiac troponin T; MRI, magnetic resonance imaging; RTP, return to play.